CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Automatic closed-loop insulin delivery +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02366767
NCT02366767N/ACompleted
CompareCT.gov

Assessment of an Automatic Closed-loop Insulin Delivery System

Stanford University·interventional·Posted Feb 19, 2015·Updated Mar 17, 2017

In Brief

A clinical study evaluating Automatic closed-loop insulin delivery and Control for Diabetes Mellitus, Type 1. Completed, enrolled 21 participants across 3 sites.

Detailed Summary

The overall aim of this research proposal is to determine the safety, feasibility and efficacy of an automatic closed-loop insulin delivery system.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesUnited States
CollaboratorsMedtronic

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 19, 2015
Enrollment StartJun 1, 2014
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 11.4 years ago

Interventions

Automatic closed-loop insulin deliverydevice

Sensor transmit glucose data every 5 minutes to the control algorithm which adjusts insulin delivery every 5 minutes.

Controldevice

Threshold suspend